An increase in clotting factor VII (P = 0.02), without changes in fibrinogen or factor X levels, occurred in the MaxEPA group. Similar reductions in blood pressure were observed in both groups. Dietary supplementation with MaxEPA capsules (10 g/day) in NIDDM subjects is associated with improvement in hypertriglyceridemia but with deleterious effects in factor VII and blood glucose levels. Most indices of platelet function are unaffected by this therapy.

Fish Oil

Health conditions analyzed in this study

Functions related to this study

Heart health

1 supplement Highly Positive Fish Oil

---

Body systems related to this study

Cardiovascular System

1 supplement Fish Oil